BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 31818158)

  • 1. US-guided Percutaneous Radiofrequency Ablation for Secondary Hyperparathyroidism: Long-term Outcomes and Prognostic Factors.
    Yue W; Jiang T; Ai Z; Deng E; Chai H; Li X; He H; Zhang Z; Weng N; Qin X; Fan J; Tang X; Heng W; Li Y; Sun L; Peng C; Xu H
    Radiology; 2024 Apr; 311(1):e231852. PubMed ID: 38625007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.
    Wei Y; Peng L; Li Y; Zhao ZL; Yu MA
    Korean J Radiol; 2020 May; 21(5):572-581. PubMed ID: 32323502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocalcemia after ultrasound-guided microwave ablation and total parathyroidectomy for secondary hyperparathyroidism: a retrospective study.
    Wei Y; Yu MA; Qian LX; Zhao ZL; Cao XJ; Peng LL; Li Y
    Int J Hyperthermia; 2020; 37(1):819-825. PubMed ID: 32633649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of US-guided thermal ablation for primary hyperparathyroidism: a systematic review and meta-analysis.
    Ye J; Huang W; Huang G; Qiu Y; Peng W; Lan N; Xie X; Liu B
    Int J Hyperthermia; 2020; 37(1):245-253. PubMed ID: 32138558
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study.
    Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Yu MA
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2707-2717. PubMed ID: 33846740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of secondary and tertiary hyperparathyroidism.
    Zhang LX; Zhang B; Liu XY; Wang ZM; Qi P; Zhang TY; Zhang Q
    Front Endocrinol (Lausanne); 2022; 13():1059828. PubMed ID: 36561571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism.
    Ni W; Yuan Y; Chu X; Chen G; Han X; Li J; Wu X; Wang J; Liu C; Xu S
    Front Endocrinol (Lausanne); 2021; 12():782050. PubMed ID: 34925241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: A meta-analysis.
    Gong L; Tang W; Lu J; Xu W
    Int J Surg; 2019 Oct; 70():13-18. PubMed ID: 31404676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications encountered in the treatment of primary and secondary hyperparathyroidism with microwave ablation - a retrospective study.
    Wei Y; Peng LL; Zhao ZL; Li Y; Yu MA
    Int J Hyperthermia; 2019; 36(1):1264-1271. PubMed ID: 31818158
    [No Abstract]   [Full Text] [Related]  

  • 10. Complications of microwave ablation in patients with persistent/recurrent hyperparathyroidism after surgical or ablative treatment.
    Wei Y; Zhao ZL; Wu J; Cao SL; Peng LL; Li Y; Yu MA
    Int J Hyperthermia; 2024; 41(1):2308063. PubMed ID: 38314664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism.
    Ma H; Ouyang C; Huang Y; Xing C; Cheng C; Liu W; Yuan D; Zeng M; Yu X; Ren H; Yuan Y; Zhang L; Xu F; Cui Y; Ren W; Huang H; Qian H; Fan B; Wang N
    Ren Fail; 2020 Nov; 42(1):66-76. PubMed ID: 31928297
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: A retrospective pilot study.
    Yu MA; Yao L; Zhang L; Peng L; Zhuo L; Zhang Y; Li W; Lv MD
    Int J Hyperthermia; 2016; 32(2):180-6. PubMed ID: 26606889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis.
    Xu W; Li S; Cheng F; Gong L; Tang W; Lu J; Li Y; Wang Z
    Int Urol Nephrol; 2023 Sep; 55(9):2237-2247. PubMed ID: 36892812
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.